Compare Twist Bioscience Corp (TWST) vs Vanguard Dividend Appreciation Index Fund ETF (VIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Twist Bioscience Corp vs Vanguard Dividend Appreciation Index Fund ETF — how do they compare? Twist Bioscience Corp trades at $125.52 (market cap $8.26B), while Vanguard Dividend Appreciation Index Fund ETF trades at $239.88. Which is the better fit depends on your goals.
| TWST | VIG | |
|---|---|---|
Market Cap | $8.26B | — |
Sector | Health | — |
52-Week High | $153.10 | $246.61 |
52-Week Low | $24.16 | $210.70 |
Enterprise Value | $8.18B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Twist Bioscience (TWST) trades at $128.06, up 2.68% with a bearish technical signal despite recent AI-driven momentum. The company shows strong revenue growth (2025: $377M, 2026: $432M projected) but continues to report significant losses with negative net margins. Recent news highlights AI partnerships and a $300M stock offering, while analyst consensus remains predominantly bullish with 78.6% buy ratings.
TWST presents a high-risk growth opportunity with accelerating revenue but persistent profitability challenges. The stock's valuation appears stretched at P/S of 18.09, requiring successful execution on AI initiatives and path to EBITDA breakeven. Key risks include cash burn, competitive pressures, and dependence on emerging AI-driven drug discovery markets.
VIG trades at $240.11, down 0.79% on the day, with a bearish technical signal from moving averages but neutral oscillators. The ETF focuses on dividend growth, with a dividend of $1.00 scheduled for June 2026. Recent news highlights its role in retirement portfolios and comparisons with peers like SCHD and DGRO, emphasizing its defensive tech exposure and lower yield strategy.
The outlook for VIG hinges on its dividend growth approach amid market volatility. Opportunities include steady income appeal for long-term investors, while risks involve underperformance if high-yield alternatives gain favor or economic conditions pressure dividend sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →About Vanguard Dividend Appreciation Index Fund ETF
The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that have a record of increasing dividends over time. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VIG →
